Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report offers an overview of the market trends, drivers, and barriers with respect to the China Friedreich Ataxia Drug market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Friedreich Ataxia Drug market. Detailed analysis of key players, along with key growth strategies adopted by Friedreich Ataxia Drug industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
STATegics Inc
Shire Plc
Forward Pharma A/S
ProQR Therapeutics NV
RaNA Therapeutics Inc
Reata Pharmaceuticals Inc
Ixchel Pharma LLC
Cardero Therapeutics Inc
Adverum Biotechnologies Inc
Retrotope Inc
Pfizer Inc
Voyager Therapeutics Inc
By Type:
ADVM-063
AGIL-FA
BHV-4157
BVA-202
Others
By End-User:
Clinic
Hospital
Others
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Friedreich Ataxia Drug Market
-
1.3 Market Segment by Type
-
1.3.1 China Friedreich Ataxia Drug Market Size and Growth Rate of ADVM-063 from 2016 to 2027
-
1.3.2 China Friedreich Ataxia Drug Market Size and Growth Rate of AGIL-FA from 2016 to 2027
-
1.3.3 China Friedreich Ataxia Drug Market Size and Growth Rate of BHV-4157 from 2016 to 2027
-
1.3.4 China Friedreich Ataxia Drug Market Size and Growth Rate of BVA-202 from 2016 to 2027
-
1.3.5 China Friedreich Ataxia Drug Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Friedreich Ataxia Drug Market Size and Growth Rate of Clinic from 2016 to 2027
-
1.4.2 China Friedreich Ataxia Drug Market Size and Growth Rate of Hospital from 2016 to 2027
-
1.4.3 China Friedreich Ataxia Drug Market Size and Growth Rate of Others from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Friedreich Ataxia Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Friedreich Ataxia Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Friedreich Ataxia Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Friedreich Ataxia Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Friedreich Ataxia Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Friedreich Ataxia Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Friedreich Ataxia Drug Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Friedreich Ataxia Drug Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Friedreich Ataxia Drug by Major Types
-
3.4.1 Market Size and Growth Rate of ADVM-063
-
3.4.2 Market Size and Growth Rate of AGIL-FA
-
3.4.3 Market Size and Growth Rate of BHV-4157
-
3.4.4 Market Size and Growth Rate of BVA-202
-
3.4.5 Market Size and Growth Rate of Others
4 Segmentation of Friedreich Ataxia Drug Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Friedreich Ataxia Drug by Major End-Users
-
4.4.1 Market Size and Growth Rate of Friedreich Ataxia Drug in Clinic
-
4.4.2 Market Size and Growth Rate of Friedreich Ataxia Drug in Hospital
-
4.4.3 Market Size and Growth Rate of Friedreich Ataxia Drug in Others
5 Market Analysis by Regions
-
5.1 China Friedreich Ataxia Drug Production Analysis by Regions
-
5.2 China Friedreich Ataxia Drug Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Friedreich Ataxia Drug Landscape Analysis
-
6.1 North China Friedreich Ataxia Drug Landscape Analysis by Major Types
-
6.2 North China Friedreich Ataxia Drug Landscape Analysis by Major End-Users
7 Central China Friedreich Ataxia Drug Landscape Analysis
-
7.1 Central China Friedreich Ataxia Drug Landscape Analysis by Major Types
-
7.2 Central China Friedreich Ataxia Drug Landscape Analysis by Major End-Users
8 South China Friedreich Ataxia Drug Landscape Analysis
-
8.1 South China Friedreich Ataxia Drug Landscape Analysis by Major Types
-
8.2 South China Friedreich Ataxia Drug Landscape Analysis by Major End-Users
9 East China Friedreich Ataxia Drug Landscape Analysis
-
9.1 East China Friedreich Ataxia Drug Landscape Analysis by Major Types
-
9.2 East China Friedreich Ataxia Drug Landscape Analysis by Major End-Users
10 Northeast China Friedreich Ataxia Drug Landscape Analysis
-
10.1 Northeast China Friedreich Ataxia Drug Landscape Analysis by Major Types
-
10.2 Northeast China Friedreich Ataxia Drug Landscape Analysis by Major End-Users
11 Southwest China Friedreich Ataxia Drug Landscape Analysis
-
11.1 Southwest China Friedreich Ataxia Drug Landscape Analysis by Major Types
-
11.2 Southwest China Friedreich Ataxia Drug Landscape Analysis by Major End-Users
12 Northwest China Friedreich Ataxia Drug Landscape Analysis
-
12.1 Northwest China Friedreich Ataxia Drug Landscape Analysis by Major Types
-
12.2 Northwest China Friedreich Ataxia Drug Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 STATegics Inc
-
13.1.1 STATegics Inc Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Shire Plc
-
13.2.1 Shire Plc Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Forward Pharma A/S
-
13.3.1 Forward Pharma A/S Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 ProQR Therapeutics NV
-
13.4.1 ProQR Therapeutics NV Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 RaNA Therapeutics Inc
-
13.5.1 RaNA Therapeutics Inc Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Reata Pharmaceuticals Inc
-
13.6.1 Reata Pharmaceuticals Inc Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 Ixchel Pharma LLC
-
13.7.1 Ixchel Pharma LLC Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Cardero Therapeutics Inc
-
13.8.1 Cardero Therapeutics Inc Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Adverum Biotechnologies Inc
-
13.9.1 Adverum Biotechnologies Inc Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Retrotope Inc
-
13.10.1 Retrotope Inc Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 Pfizer Inc
-
13.11.1 Pfizer Inc Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
-
13.12 Voyager Therapeutics Inc
-
13.12.1 Voyager Therapeutics Inc Company Profile and Recent Development
-
13.12.2 Market Performance
-
13.12.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Friedreich Ataxia Drug Market Size and Growth Rate of ADVM-063 from 2016 to 2027
-
Figure China Friedreich Ataxia Drug Market Size and Growth Rate of AGIL-FA from 2016 to 2027
-
Figure China Friedreich Ataxia Drug Market Size and Growth Rate of BHV-4157 from 2016 to 2027
-
Figure China Friedreich Ataxia Drug Market Size and Growth Rate of BVA-202 from 2016 to 2027
-
Figure China Friedreich Ataxia Drug Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Friedreich Ataxia Drug Market Size and Growth Rate of Clinic from 2016 to 2027
-
Figure China Friedreich Ataxia Drug Market Size and Growth Rate of Hospital from 2016 to 2027
-
Figure China Friedreich Ataxia Drug Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Friedreich Ataxia Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Friedreich Ataxia Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Friedreich Ataxia Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Friedreich Ataxia Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Friedreich Ataxia Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Friedreich Ataxia Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Friedreich Ataxia Drug Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Friedreich Ataxia Drug Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Friedreich Ataxia Drug
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Friedreich Ataxia Drug by Different Types from 2016 to 2027
-
Table Consumption Share of Friedreich Ataxia Drug by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of ADVM-063
-
Figure Market Size and Growth Rate of AGIL-FA
-
Figure Market Size and Growth Rate of BHV-4157
-
Figure Market Size and Growth Rate of BVA-202
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Friedreich Ataxia Drug by Different End-Users from 2016 to 2027
-
Table Consumption Share of Friedreich Ataxia Drug by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Clinic
-
Figure Market Size and Growth Rate of Hospital
-
Figure Market Size and Growth Rate of Others
-
Table China Friedreich Ataxia Drug Production by Regions
-
Table China Friedreich Ataxia Drug Production Share by Regions
-
Figure China Friedreich Ataxia Drug Production Share by Regions in 2016
-
Figure China Friedreich Ataxia Drug Production Share by Regions in 2021
-
Figure China Friedreich Ataxia Drug Production Share by Regions in 2027
-
Table China Friedreich Ataxia Drug Consumption by Regions
-
Table China Friedreich Ataxia Drug Consumption Share by Regions
-
Figure China Friedreich Ataxia Drug Consumption Share by Regions in 2016
-
Figure China Friedreich Ataxia Drug Consumption Share by Regions in 2021
-
Figure China Friedreich Ataxia Drug Consumption Share by Regions in 2027
-
Table North China Friedreich Ataxia Drug Consumption by Types from 2016 to 2027
-
Table North China Friedreich Ataxia Drug Consumption Share by Types from 2016 to 2027
-
Figure North China Friedreich Ataxia Drug Consumption Share by Types in 2016
-
Figure North China Friedreich Ataxia Drug Consumption Share by Types in 2021
-
Figure North China Friedreich Ataxia Drug Consumption Share by Types in 2027
-
Table North China Friedreich Ataxia Drug Consumption by End-Users from 2016 to 2027
-
Table North China Friedreich Ataxia Drug Consumption Share by End-Users from 2016 to 2027
-
Figure North China Friedreich Ataxia Drug Consumption Share by End-Users in 2016
-
Figure North China Friedreich Ataxia Drug Consumption Share by End-Users in 2021
-
Figure North China Friedreich Ataxia Drug Consumption Share by End-Users in 2027
-
Table Central China Friedreich Ataxia Drug Consumption by Types from 2016 to 2027
-
Table Central China Friedreich Ataxia Drug Consumption Share by Types from 2016 to 2027
-
Figure Central China Friedreich Ataxia Drug Consumption Share by Types in 2016
-
Figure Central China Friedreich Ataxia Drug Consumption Share by Types in 2021
-
Figure Central China Friedreich Ataxia Drug Consumption Share by Types in 2027
-
Table Central China Friedreich Ataxia Drug Consumption by End-Users from 2016 to 2027
-
Table Central China Friedreich Ataxia Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Friedreich Ataxia Drug Consumption Share by End-Users in 2016
-
Figure Central China Friedreich Ataxia Drug Consumption Share by End-Users in 2021
-
Figure Central China Friedreich Ataxia Drug Consumption Share by End-Users in 2027
-
Table South China Friedreich Ataxia Drug Consumption by Types from 2016 to 2027
-
Table South China Friedreich Ataxia Drug Consumption Share by Types from 2016 to 2027
-
Figure South China Friedreich Ataxia Drug Consumption Share by Types in 2016
-
Figure South China Friedreich Ataxia Drug Consumption Share by Types in 2021
-
Figure South China Friedreich Ataxia Drug Consumption Share by Types in 2027
-
Table South China Friedreich Ataxia Drug Consumption by End-Users from 2016 to 2027
-
Table South China Friedreich Ataxia Drug Consumption Share by End-Users from 2016 to 2027
-
Figure South China Friedreich Ataxia Drug Consumption Share by End-Users in 2016
-
Figure South China Friedreich Ataxia Drug Consumption Share by End-Users in 2021
-
Figure South China Friedreich Ataxia Drug Consumption Share by End-Users in 2027
-
Table East China Friedreich Ataxia Drug Consumption by Types from 2016 to 2027
-
Table East China Friedreich Ataxia Drug Consumption Share by Types from 2016 to 2027
-
Figure East China Friedreich Ataxia Drug Consumption Share by Types in 2016
-
Figure East China Friedreich Ataxia Drug Consumption Share by Types in 2021
-
Figure East China Friedreich Ataxia Drug Consumption Share by Types in 2027
-
Table East China Friedreich Ataxia Drug Consumption by End-Users from 2016 to 2027
-
Table East China Friedreich Ataxia Drug Consumption Share by End-Users from 2016 to 2027
-
Figure East China Friedreich Ataxia Drug Consumption Share by End-Users in 2016
-
Figure East China Friedreich Ataxia Drug Consumption Share by End-Users in 2021
-
Figure East China Friedreich Ataxia Drug Consumption Share by End-Users in 2027
-
Table Northeast China Friedreich Ataxia Drug Consumption by Types from 2016 to 2027
-
Table Northeast China Friedreich Ataxia Drug Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Friedreich Ataxia Drug Consumption Share by Types in 2016
-
Figure Northeast China Friedreich Ataxia Drug Consumption Share by Types in 2021
-
Figure Northeast China Friedreich Ataxia Drug Consumption Share by Types in 2027
-
Table Northeast China Friedreich Ataxia Drug Consumption by End-Users from 2016 to 2027
-
Table Northeast China Friedreich Ataxia Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Friedreich Ataxia Drug Consumption Share by End-Users in 2016
-
Figure Northeast China Friedreich Ataxia Drug Consumption Share by End-Users in 2021
-
Figure Northeast China Friedreich Ataxia Drug Consumption Share by End-Users in 2027
-
Table Southwest China Friedreich Ataxia Drug Consumption by Types from 2016 to 2027
-
Table Southwest China Friedreich Ataxia Drug Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Friedreich Ataxia Drug Consumption Share by Types in 2016
-
Figure Southwest China Friedreich Ataxia Drug Consumption Share by Types in 2021
-
Figure Southwest China Friedreich Ataxia Drug Consumption Share by Types in 2027
-
Table Southwest China Friedreich Ataxia Drug Consumption by End-Users from 2016 to 2027
-
Table Southwest China Friedreich Ataxia Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Friedreich Ataxia Drug Consumption Share by End-Users in 2016
-
Figure Southwest China Friedreich Ataxia Drug Consumption Share by End-Users in 2021
-
Figure Southwest China Friedreich Ataxia Drug Consumption Share by End-Users in 2027
-
Table Northwest China Friedreich Ataxia Drug Consumption by Types from 2016 to 2027
-
Table Northwest China Friedreich Ataxia Drug Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Friedreich Ataxia Drug Consumption Share by Types in 2016
-
Figure Northwest China Friedreich Ataxia Drug Consumption Share by Types in 2021
-
Figure Northwest China Friedreich Ataxia Drug Consumption Share by Types in 2027
-
Table Northwest China Friedreich Ataxia Drug Consumption by End-Users from 2016 to 2027
-
Table Northwest China Friedreich Ataxia Drug Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Friedreich Ataxia Drug Consumption Share by End-Users in 2016
-
Figure Northwest China Friedreich Ataxia Drug Consumption Share by End-Users in 2021
-
Figure Northwest China Friedreich Ataxia Drug Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of STATegics Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of STATegics Inc
-
Figure Sales and Growth Rate Analysis of STATegics Inc
-
Figure Revenue and Market Share Analysis of STATegics Inc
-
Table Product and Service Introduction of STATegics Inc
-
Table Company Profile and Development Status of Shire Plc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shire Plc
-
Figure Sales and Growth Rate Analysis of Shire Plc
-
Figure Revenue and Market Share Analysis of Shire Plc
-
Table Product and Service Introduction of Shire Plc
-
Table Company Profile and Development Status of Forward Pharma A/S
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Forward Pharma A/S
-
Figure Sales and Growth Rate Analysis of Forward Pharma A/S
-
Figure Revenue and Market Share Analysis of Forward Pharma A/S
-
Table Product and Service Introduction of Forward Pharma A/S
-
Table Company Profile and Development Status of ProQR Therapeutics NV
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of ProQR Therapeutics NV
-
Figure Sales and Growth Rate Analysis of ProQR Therapeutics NV
-
Figure Revenue and Market Share Analysis of ProQR Therapeutics NV
-
Table Product and Service Introduction of ProQR Therapeutics NV
-
Table Company Profile and Development Status of RaNA Therapeutics Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of RaNA Therapeutics Inc
-
Figure Sales and Growth Rate Analysis of RaNA Therapeutics Inc
-
Figure Revenue and Market Share Analysis of RaNA Therapeutics Inc
-
Table Product and Service Introduction of RaNA Therapeutics Inc
-
Table Company Profile and Development Status of Reata Pharmaceuticals Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Reata Pharmaceuticals Inc
-
Figure Sales and Growth Rate Analysis of Reata Pharmaceuticals Inc
-
Figure Revenue and Market Share Analysis of Reata Pharmaceuticals Inc
-
Table Product and Service Introduction of Reata Pharmaceuticals Inc
-
Table Company Profile and Development Status of Ixchel Pharma LLC
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Ixchel Pharma LLC
-
Figure Sales and Growth Rate Analysis of Ixchel Pharma LLC
-
Figure Revenue and Market Share Analysis of Ixchel Pharma LLC
-
Table Product and Service Introduction of Ixchel Pharma LLC
-
Table Company Profile and Development Status of Cardero Therapeutics Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Cardero Therapeutics Inc
-
Figure Sales and Growth Rate Analysis of Cardero Therapeutics Inc
-
Figure Revenue and Market Share Analysis of Cardero Therapeutics Inc
-
Table Product and Service Introduction of Cardero Therapeutics Inc
-
Table Company Profile and Development Status of Adverum Biotechnologies Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Adverum Biotechnologies Inc
-
Figure Sales and Growth Rate Analysis of Adverum Biotechnologies Inc
-
Figure Revenue and Market Share Analysis of Adverum Biotechnologies Inc
-
Table Product and Service Introduction of Adverum Biotechnologies Inc
-
Table Company Profile and Development Status of Retrotope Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Retrotope Inc
-
Figure Sales and Growth Rate Analysis of Retrotope Inc
-
Figure Revenue and Market Share Analysis of Retrotope Inc
-
Table Product and Service Introduction of Retrotope Inc
-
Table Company Profile and Development Status of Pfizer Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer Inc
-
Figure Sales and Growth Rate Analysis of Pfizer Inc
-
Figure Revenue and Market Share Analysis of Pfizer Inc
-
Table Product and Service Introduction of Pfizer Inc
-
Table Company Profile and Development Status of Voyager Therapeutics Inc
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Voyager Therapeutics Inc
-
Figure Sales and Growth Rate Analysis of Voyager Therapeutics Inc
-
Figure Revenue and Market Share Analysis of Voyager Therapeutics Inc
-
Table Product and Service Introduction of Voyager Therapeutics Inc
-
